Annual SG&A:
$215.31M+$41.70M(+24.02%)Summary
- As of today, CYTK annual SG&A is $215.31 million, with the most recent change of +$41.70 million (+24.02%) on December 31, 2024.
- During the last 3 years, CYTK annual SG&A has risen by +$118.51 million (+122.42%).
- CYTK annual SG&A is now at all-time high.
Performance
CYTK SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$65.72M+$8.35M(+14.56%)Summary
- As of today, CYTK quarterly SG&A is $65.72 million, with the most recent change of +$8.35 million (+14.56%) on June 30, 2025.
- Over the past year, CYTK quarterly SG&A has increased by +$14.90 million (+29.31%).
- CYTK quarterly SG&A is now at all-time high.
Performance
CYTK Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$11.11B-$606.31M(-5.77%)Summary
- As of today, CYTK TTM SG&A is -$11.11 billion, with the most recent change of -$606.31 million (-5.77%) on June 30, 2025.
- Over the past year, CYTK TTM SG&A has dropped by -$11.29 billion (-6255.76%).
- CYTK TTM SG&A is now -23019.57% below its all-time high of $48.49 million.
Performance
CYTK TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
CYTK Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +24.0% | +29.3% | -6255.8% |
| 3Y3 Years | +122.4% | +53.9% | -8284.6% |
| 5Y5 Years | +443.6% | +364.1% | -10000.0% |
CYTK Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +122.4% | at high | +65.5% | -111.7% | at low |
| 5Y | 5-Year | at high | +443.6% | at high | +434.2% | -203.4% | at low |
| All-Time | All-Time | at high | +6251.4% | at high | +2555.4% | >-9999.0% | at low |
CYTK Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $65.72M(+14.6%) | $242.08M(+6.6%) |
| Mar 2025 | - | $57.37M(-8.0%) | $227.18M(+5.5%) |
| Dec 2024 | $215.31M(+24.0%) | $62.34M(+10.0%) | $215.31M(+9.2%) |
| Sep 2024 | - | $56.65M(+11.5%) | $197.09M(+9.2%) |
| Jun 2024 | - | $50.82M(+11.7%) | $180.55M(+6.6%) |
| Mar 2024 | - | $45.50M(+3.1%) | $169.45M(-2.4%) |
| Dec 2023 | $173.61M(-2.5%) | $44.11M(+10.0%) | $173.61M(-5.4%) |
| Sep 2023 | - | $40.11M(+1.0%) | $183.47M(-4.2%) |
| Jun 2023 | - | $39.72M(-20.0%) | $191.58M(-1.5%) |
| Mar 2023 | - | $49.66M(-8.0%) | $194.57M(+9.3%) |
| Dec 2022 | $177.98M(+83.9%) | $53.97M(+11.9%) | $177.98M(+12.8%) |
| Sep 2022 | - | $48.22M(+12.9%) | $157.81M(+16.2%) |
| Jun 2022 | - | $42.72M(+29.2%) | $135.79M(+18.8%) |
| Mar 2022 | - | $33.07M(-2.2%) | $114.28M(+18.0%) |
| Dec 2021 | $96.80M(+83.3%) | $33.81M(+29.0%) | $96.80M(+25.9%) |
| Sep 2021 | - | $26.20M(+23.6%) | $76.91M(+22.1%) |
| Jun 2021 | - | $21.20M(+35.9%) | $63.01M(+12.6%) |
| Mar 2021 | - | $15.60M(+12.2%) | $55.97M(+6.0%) |
| Dec 2020 | $52.82M(+33.4%) | $13.91M(+13.1%) | $52.82M(+6.7%) |
| Sep 2020 | - | $12.30M(-13.1%) | $49.50M(+5.4%) |
| Jun 2020 | - | $14.16M(+13.8%) | $46.95M(+10.1%) |
| Mar 2020 | - | $12.45M(+17.6%) | $42.62M(+7.6%) |
| Dec 2019 | $39.61M(+26.6%) | $10.58M(+8.5%) | $39.61M(+8.3%) |
| Sep 2019 | - | $9.75M(-0.8%) | $36.58M(+7.6%) |
| Jun 2019 | - | $9.84M(+4.2%) | $33.99M(+5.6%) |
| Mar 2019 | - | $9.44M(+24.9%) | $32.20M(+0.5%) |
| Dec 2018 | $31.28M(-14.2%) | $7.56M(+5.5%) | $32.03M(-7.8%) |
| Sep 2018 | - | $7.16M(-11.0%) | $34.73M(-6.7%) |
| Jun 2018 | - | $8.05M(-13.1%) | $37.23M(-1.0%) |
| Mar 2018 | - | $9.26M(-9.7%) | $37.62M(+3.2%) |
| Dec 2017 | $36.47M(+31.1%) | $10.26M(+6.2%) | $36.47M(+10.9%) |
| Sep 2017 | - | $9.66M(+14.4%) | $32.88M(+8.0%) |
| Jun 2017 | - | $8.44M(+4.0%) | $30.45M(+4.6%) |
| Mar 2017 | - | $8.12M(+21.6%) | $29.10M(+4.6%) |
| Dec 2016 | $27.82M(+41.5%) | $6.67M(-7.5%) | $27.82M(+4.3%) |
| Sep 2016 | - | $7.22M(+1.8%) | $26.68M(+7.8%) |
| Jun 2016 | - | $7.09M(+3.6%) | $24.74M(+11.7%) |
| Mar 2016 | - | $6.84M(+23.7%) | $22.14M(+12.6%) |
| Dec 2015 | $19.67M(+13.9%) | $5.53M(+4.8%) | $19.67M(+5.2%) |
| Sep 2015 | - | $5.28M(+17.4%) | $18.70M(+7.4%) |
| Jun 2015 | - | $4.50M(+2.9%) | $17.41M(+0.2%) |
| Mar 2015 | - | $4.37M(-4.2%) | $17.38M(+0.6%) |
| Dec 2014 | $17.27M | $4.56M(+14.1%) | $17.27M(+2.8%) |
| Sep 2014 | - | $3.99M(-10.4%) | $16.80M(+2.2%) |
| Jun 2014 | - | $4.46M(+4.7%) | $16.45M(+4.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | $4.26M(+4.1%) | $15.72M(+4.1%) |
| Dec 2013 | $15.09M(+21.4%) | $4.09M(+12.6%) | $15.09M(+1.9%) |
| Sep 2013 | - | $3.63M(-2.5%) | $14.81M(+4.5%) |
| Jun 2013 | - | $3.73M(+2.6%) | $14.17M(+8.9%) |
| Mar 2013 | - | $3.63M(-4.7%) | $13.01M(+4.7%) |
| Dec 2012 | $12.43M(-8.5%) | $3.81M(+27.5%) | $12.43M(+8.3%) |
| Sep 2012 | - | $2.99M(+16.5%) | $11.48M(+0.4%) |
| Jun 2012 | - | $2.57M(-16.0%) | $11.44M(-9.7%) |
| Mar 2012 | - | $3.06M(+6.7%) | $12.66M(+1.1%) |
| Dec 2011 | $13.59M(-4.3%) | $2.86M(-2.9%) | $12.52M(-5.3%) |
| Sep 2011 | - | $2.95M(-22.3%) | $13.23M(-3.4%) |
| Jun 2011 | - | $3.80M(+30.3%) | $13.69M(+3.1%) |
| Mar 2011 | - | $2.91M(-18.4%) | $13.28M(-6.5%) |
| Dec 2010 | $14.20M(-9.1%) | $3.57M(+4.6%) | $14.20M(-0.2%) |
| Sep 2010 | - | $3.41M(+0.9%) | $14.23M(-3.2%) |
| Jun 2010 | - | $3.38M(-11.9%) | $14.70M(-4.8%) |
| Mar 2010 | - | $3.84M(+6.5%) | $15.44M(-1.2%) |
| Dec 2009 | $15.63M(+3.6%) | $3.60M(-7.1%) | $15.63M(+5.1%) |
| Sep 2009 | - | $3.88M(-6.0%) | $14.87M(+0.4%) |
| Jun 2009 | - | $4.13M(+2.7%) | $14.81M(-0.8%) |
| Mar 2009 | - | $4.02M(+41.5%) | $14.94M(-0.9%) |
| Dec 2008 | $15.08M(-9.8%) | $2.84M(-25.7%) | $15.08M(-7.8%) |
| Sep 2008 | - | $3.83M(-10.0%) | $16.34M(-1.7%) |
| Jun 2008 | - | $4.25M(+2.3%) | $16.63M(+1.4%) |
| Mar 2008 | - | $4.16M(+1.1%) | $16.39M(-1.9%) |
| Dec 2007 | $16.72M(+9.7%) | $4.11M(-0.1%) | $16.72M(+0.0%) |
| Sep 2007 | - | $4.11M(+2.4%) | $16.72M(+3.3%) |
| Jun 2007 | - | $4.01M(-10.4%) | $16.18M(+0.5%) |
| Mar 2007 | - | $4.48M(+9.1%) | $16.10M(+5.6%) |
| Dec 2006 | $15.24M(+17.5%) | $4.11M(+15.0%) | $15.24M(+7.1%) |
| Sep 2006 | - | $3.57M(-9.3%) | $14.24M(+1.8%) |
| Jun 2006 | - | $3.94M(+8.7%) | $13.99M(+4.0%) |
| Mar 2006 | - | $3.62M(+16.7%) | $13.46M(+3.7%) |
| Dec 2005 | $12.97M(+8.2%) | $3.10M(-6.6%) | $12.98M(-1.3%) |
| Sep 2005 | - | $3.33M(-2.3%) | $13.15M(-1.8%) |
| Jun 2005 | - | $3.40M(+8.3%) | $13.39M(+5.8%) |
| Mar 2005 | - | $3.14M(-4.0%) | $12.66M(+5.6%) |
| Dec 2004 | $11.99M(+33.6%) | $3.27M(-8.2%) | $11.99M(+37.6%) |
| Sep 2004 | - | $3.57M(+33.6%) | $8.72M(+69.3%) |
| Jun 2004 | - | $2.67M(+8.0%) | $5.15M(+108.0%) |
| Mar 2004 | - | $2.48M | $2.48M |
| Dec 2003 | $8.97M(+29.0%) | - | - |
| Dec 2002 | $6.95M(+17.9%) | - | - |
| Dec 2001 | $5.90M(+74.0%) | - | - |
| Dec 2000 | $3.39M | - | - |
FAQ
- What is Cytokinetics, Incorporated annual SG&A?
- What is the all-time high annual SG&A for Cytokinetics, Incorporated?
- What is Cytokinetics, Incorporated annual SG&A year-on-year change?
- What is Cytokinetics, Incorporated quarterly SG&A?
- What is the all-time high quarterly SG&A for Cytokinetics, Incorporated?
- What is Cytokinetics, Incorporated quarterly SG&A year-on-year change?
- What is Cytokinetics, Incorporated TTM SG&A?
- What is the all-time high TTM SG&A for Cytokinetics, Incorporated?
- What is Cytokinetics, Incorporated TTM SG&A year-on-year change?
What is Cytokinetics, Incorporated annual SG&A?
The current annual SG&A of CYTK is $215.31M
What is the all-time high annual SG&A for Cytokinetics, Incorporated?
Cytokinetics, Incorporated all-time high annual SG&A is $215.31M
What is Cytokinetics, Incorporated annual SG&A year-on-year change?
Over the past year, CYTK annual SG&A has changed by +$41.70M (+24.02%)
What is Cytokinetics, Incorporated quarterly SG&A?
The current quarterly SG&A of CYTK is $65.72M
What is the all-time high quarterly SG&A for Cytokinetics, Incorporated?
Cytokinetics, Incorporated all-time high quarterly SG&A is $65.72M
What is Cytokinetics, Incorporated quarterly SG&A year-on-year change?
Over the past year, CYTK quarterly SG&A has changed by +$14.90M (+29.31%)
What is Cytokinetics, Incorporated TTM SG&A?
The current TTM SG&A of CYTK is -$11.11B
What is the all-time high TTM SG&A for Cytokinetics, Incorporated?
Cytokinetics, Incorporated all-time high TTM SG&A is $48.49M
What is Cytokinetics, Incorporated TTM SG&A year-on-year change?
Over the past year, CYTK TTM SG&A has changed by -$11.29B (-6255.76%)